0001209191-19-044456.txt : 20190805 0001209191-19-044456.hdr.sgml : 20190805 20190805143328 ACCESSION NUMBER: 0001209191-19-044456 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190801 FILED AS OF DATE: 20190805 DATE AS OF CHANGE: 20190805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARVIS WILLIAM GEORGE CENTRAL INDEX KEY: 0001784345 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28132 FILM NUMBER: 19998313 MAIL ADDRESS: STREET 1: 1175 PEACHTREE STREET NE STREET 2: 10TH FLOOR CITY: ATLANTA STATE: GA ZIP: 30361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STREAMLINE HEALTH SOLUTIONS INC. CENTRAL INDEX KEY: 0001008586 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 311455414 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 1230 PEACHTREE STREET NE STREET 2: SUITE 600 CITY: ATLANTA STATE: GA ZIP: 30309 BUSINESS PHONE: 404-446-2052 MAIL ADDRESS: STREET 1: 1230 PEACHTREE STREET NE STREET 2: SUITE 600 CITY: ATLANTA STATE: GA ZIP: 30309 FORMER COMPANY: FORMER CONFORMED NAME: STREEAMLINE HEALTH SOLUTIONS INC. DATE OF NAME CHANGE: 20060809 FORMER COMPANY: FORMER CONFORMED NAME: LANVISION SYSTEMS INC DATE OF NAME CHANGE: 19960220 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-08-01 0 0001008586 STREAMLINE HEALTH SOLUTIONS INC. STRM 0001784345 GARVIS WILLIAM GEORGE 1175 PEACHTREE STREET NE, 10TH FLOOR ATLANTA GA 30361 0 1 0 0 SVP & COO Common Stock, $.01 par value 50000 D Common Stock, $.01 par value 100000 D Stock Option (right to buy) 1.19 2026-05-22 Common Stock, $0.01 Par Value 50000 D Stock Option (right to buy) 1.18 2027-03-02 Common Stock, $0.01 Par Value 25000 D Represents an award of Restricted Stock granted outside the Streamline Health Solutions, Inc. Second Amended and Restated 2013 Stock Incentive Plan to the Reporting Person on August 1, 2019, which vests, assuming continued employment, in four substantially equal installments on November 1, 2019, February 1, 2020, May 1, 2020 and August 1, 2020. Represents an award of Restricted Stock, which vests, assuming continued employment, in three substantially equal installments: 33% on January 29, 2020, 33% January 29, 2021, and 34% January 29, 2022. The stock options shall vest and become exercisable in three substantially equal annual installments commencing on May 23, 2017, subject to the provisions in the agreement relating to the effect of termination of employment. The stock options shall vest and become exercisable in thirty-six substantially equal monthly installments commencing on April 2, 2017, subject to the provisions in the agreement relating to the effect of termination of employment. /s/ Thomas Gibson, as attorney-in-fact 2019-08-02